• Profile
Close

A novel submucosal injection solution for endoscopic resection of large colorectal lesions: A randomized, double-blind trial

Gastrointestinal Endoscopy May 25, 2018

Repici A, et al. - Given that SIC-8000 (Eleview) is a new FDA-approved solution for submucosal injection developed to provide a long-lasting cushion to facilitate endoscopic resection maneuvers, the researchers compared the efficacy and safety of SIC-8000 with those of saline solution, when performing endoscopic mucosal resection (EMR) of large colorectal lesions. The results obtained from this randomized double-blind trial indicate that a new FDA approved agent for sub-mucosal injection seemed to be a more powerful and equally safe submucosal agent for EMR injection than saline solution.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay